Shopping Cart
- Remove All
- Your shopping cart is currently empty
TRK-IN-17 is a potent inhibitor of TRK, specifically targeting tropomyosin-related kinase (Trk), a receptor tyrosine kinase activated by neurotrophic factors, which include nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophic factor-3 (NT-3), and neurotrophic factor-4/5 (NT-4/5). TRK-IN-17 has potential for cancer disease research.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $2,140 | 8-10 weeks | |
50 mg | $2,785 | 8-10 weeks | |
100 mg | $3,520 | 8-10 weeks |
Description | TRK-IN-17 is a potent inhibitor of TRK, specifically targeting tropomyosin-related kinase (Trk), a receptor tyrosine kinase activated by neurotrophic factors, which include nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophic factor-3 (NT-3), and neurotrophic factor-4/5 (NT-4/5). TRK-IN-17 has potential for cancer disease research. |
Molecular Weight | 441.5 |
Formula | C21H21F2N7S |
Cas No. | 2409544-80-3 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.